Suven to acquire a majority stake in CDMO player ‘Sapala Organics’
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
New Board of Directors and management team at Suven Pharma also appointed
Subscribe To Our Newsletter & Stay Updated